Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate S1 capsule plus Cisplatin as adjuvant treatment in
stageⅡ and Ⅲa non-small cell lung cancer. It is the first study in the world to investigate
the safety and efficacy of S1 capsule using in stageⅡ and Ⅲa non-small cell lung cancer
patients after the complete resection.